Industrial Goods » Precision Products | PerkinElmer Inc.

PerkinElmer Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
173
175
238
359
202
163
Total Accounts Receivable
470
471
415
426
552
633
Inventories
261
285
259
247
352
338
Other Current Assets
141
138
121
158
94
101
Total Current Assets
1,045
1,069
1,033
1,190
1,200
1,235
Net Property, Plant & Equipment
185
176
138
145
298
319
Total Investments and Advances
1
2
-
-
-
2
Intangible Assets
2,604
2,774
2,723
2,668
4,349
4,152
Other Assets
112
113
179
188
177
188
Total Assets
3,947
4,134
4,166
4,277
6,091
5,976
ST Debt & Current Portion LT Debt
3
1
1
1
217
Accounts Payable
167
174
141
168
222
Income Tax Payable
12
10
3
8
11
Other Current Liabilities
421
412
417
426
501
Total Current Liabilities
603
597
561
603
951
Long-Term Debt
932
1,052
1,012
1,045
1,789
Provision for Risks & Charges
-
-
48
48
13
Deferred Taxes
-
-
42
37
250
Other Liabilities
417
443
382
379
519
Total Liabilities
1,952
2,092
2,056
2,123
3,588
Common Equity (Total)
1,994
2,042
2,110
2,154
2,503
Total Shareholders' Equity
1,994
2,042
2,110
2,154
2,503
Total Equity
1,994
2,042
2,110
2,154
2,503
Liabilities & Shareholders' Equity
3,947
4,134
4,166
4,277
6,091

About PerkinElmer

View Profile
Address
940 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.perkinelmer.com
Updated 07/08/2019
PerkinElmer, Inc. (United States) engages in the provision of products, services, and solutions to diagnostics, food, environmental, industrial, life sciences research, and laboratory services markets. It operates through the Discovery and Analytical Solutions, and Diagnostics segments. The Discovery and Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments.